๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P.3.c.049 Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia

โœ Scribed by T. Jun; Y. Jeon; H. Lee; K. Lee

Book ID
118597379
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
44 KB
Volume
20
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy and safety of quetiapine for de
Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia
โœ Kyoung-Uk Lee; Yang-Whan Jeon; Hae-Kook Lee; Tae-Youn Jun ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 121 KB ๐Ÿ‘ 2 views

## Objective: To investigate the efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. ## Method: Thirty-nine patients fulfilling dsm-iv-tr diagnostic criteria for schizophrenia and had depressive symptoms were studied in a prospective 6-week open-label design

Quetiapine is effective against anxiety
Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia
โœ Siegfried Kasper ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 2 views

This analysis of data from the open-label extension (OLE) phases of three randomized clinical trials of quetiapine in patients with schizophrenia (n=415) was undertaken to investigate whether the initial improvements in anxiety and depressive symptoms were maintained during long-term treatment. The